{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:49:20Z","timestamp":1777603760848,"version":"3.51.4"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81325020"],"award-info":[{"award-number":["81325020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81361120410"],"award-info":[{"award-number":["81361120410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81761128022"],"award-info":[{"award-number":["81761128022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21772214"],"award-info":[{"award-number":["21772214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejmech.2018.02.043","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T17:05:10Z","timestamp":1518887110000},"page":"148-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential"],"prefix":"10.1016","volume":"149","author":[{"given":"Dian","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9209-0503","authenticated-orcid":false,"given":"Ya-Qiu","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.02.043_bib1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm1196-1174","article-title":"Chemokine receptors: gateways to inflammation and infection","volume":"2","author":"Premack","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-12-243","article-title":"The chemokine and chemokine receptor superfamilies and their molecular evolution","volume":"7","author":"Zlotnik","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.iy.12.040194.003113","article-title":"The molecular-biology of leukocyte chemoattractant receptors","volume":"12","author":"Murphy","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/emboj\/18.7.1723","article-title":"Molecular tinkering of G protein-coupled receptors: an evolutionary success","volume":"18","author":"Bockaert","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2018.02.043_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/pr.54.2.227","article-title":"International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature","volume":"54","author":"Murphy","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.02.043_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.02.043_bib8","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood.V95.10.3032","article-title":"Chemokine receptors and their role in inflammation and infectious diseases","volume":"95","author":"Murdoch","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib9","first-page":"95","article-title":"Chemokines and chemokine receptors: their manifold roles in homeostasis and disease","volume":"1","author":"Le","year":"2004","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/dna.1997.16.379","article-title":"Cloning of a human epididymis-specific mRNA, HE6, encoding a novel member of the seven transmembrane-domain receptor superfamily","volume":"16","author":"Osterhoff","year":"1997","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/384288a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line-adapted HIV-1","volume":"384","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib13","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1128\/JVI.73.8.6598-6609.1999","article-title":"Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates","volume":"73","author":"Chabot","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib14","doi-asserted-by":"crossref","first-page":"42826","DOI":"10.1074\/jbc.M106582200","article-title":"Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies","volume":"276","author":"Zhou","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00429","article-title":"Diversity and inter-connections in the CXCR4 chemokine receptor\/ligand family: molecular perspectives","volume":"6","author":"Pawig","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib16","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/sj.leu.2402684","article-title":"The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD\/SCID and NOD\/SCID\/B2m(null) mice","volume":"16","author":"Lapidot","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2018.02.043_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.8342023","article-title":"Signal sequence trap - a cloning strategy for secreted proteins and Type-I membrane-proteins","volume":"261","author":"Tashiro","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.02.043_bib18","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1093\/emboj\/16.23.6996","article-title":"Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1","volume":"16","author":"Crump","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2018.02.043_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jmb.2004.11.003","article-title":"Mapping the binding of the tail of the CXCR4 receptor n-terminal extracellular to stromal cell-derived factor-1 alpha","volume":"345","author":"Gozansky","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib21","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","article-title":"A\u00a0functional heteromeric MIF receptor formed by CD74 and CXCR4","volume":"583","author":"Schwartz","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2018.02.043_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cellsig.2010.08.013","article-title":"Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74","volume":"23","author":"Lue","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2018.02.043_bib23","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.1402097","article-title":"Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors","volume":"194","author":"Lourenco","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib24","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.02.043_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0092-8674(86)90590-8","article-title":"The T4 gene encodes the aids virus receptor and is expressed in the immune-system and the brain","volume":"47","author":"Maddon","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.02.043_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0042-6822(91)90904-P","article-title":"Specific cell-surface requirements for the infection of Cd4-Positive cells by human-immunodeficiency-virus Type-1 and Type-2 and by simian immunodeficiency virus","volume":"181","author":"Clapham","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2018.02.043_bib27","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKRS: a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.02.043_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.02.043_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/aid.1991.7.3","article-title":"The V3 loops of the Hiv-1 and Hiv-2 surface glycoproteins contain proteolytic cleavage sites - a possible function in viral fusion","volume":"7","author":"Clements","year":"1991","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ejmech.2018.02.043_bib32","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1096\/fasebj.7.12.7690724","article-title":"Hiv binding to its receptor creates specific epitopes for the Cd4\/Gp120 complex","volume":"7","author":"Gershoni","year":"1993","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2018.02.043_bib33","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1128\/JVI.67.12.7383-7393.1993","article-title":"Conformational-changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor-binding","volume":"67","author":"Sattentau","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.274.5287.602","article-title":"Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines","volume":"274","author":"Lapham","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.02.043_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/384184a0","article-title":"CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5","volume":"384","author":"Trkola","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/384179a0","article-title":"CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5","volume":"384","author":"Wu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.2832945","article-title":"Biologic features of Hiv-1 that correlate with virulence in the host","volume":"240","author":"Chengmayer","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.02.043_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00002030-199207000-00008","article-title":"Biphasic rate of Cd4+ cell count decline during progression to aids correlates with Hiv-1 phenotype","volume":"6","author":"Schellekens","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.ejmech.2018.02.043_bib39","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(89)92628-7","article-title":"Association between biological properties of human immunodeficiency virus variants and risk for aids and aids mortality","volume":"1","author":"Tersmette","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.02.043_bib40","first-page":"1","article-title":"Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology","author":"Tsou","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.02.043_bib41","first-page":"3530","article-title":"Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression","volume":"6","author":"Koshiba","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib42","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.4049\/jimmunol.167.8.4747","article-title":"A\u00a0possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma","volume":"167","author":"Geminder","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.043_bib44","doi-asserted-by":"crossref","first-page":"45098","DOI":"10.1074\/jbc.M106912200","article-title":"Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells","volume":"276","author":"Robledo","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V97.2.346","article-title":"Chemokine stromal cell-derived factor-1 alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1\/fibronectin and VCAM-1","volume":"97","author":"Sanz-Rodriguez","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib46","first-page":"4961","article-title":"Epithelial cancer cell migration: a role for chemokine receptors?","volume":"61","author":"Scotton","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib47","first-page":"3106","article-title":"CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma","volume":"62","author":"Bertolini","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib48","first-page":"6304","article-title":"Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-kit in small cell lung cancer cells","volume":"62","author":"Kijima","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib49","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/sj.bjc.6600221","article-title":"CXCR4\/CXCL12 expression and signalling in kidney cancer","volume":"86","author":"Schrader","year":"2002","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2018.02.043_bib50","first-page":"5930","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib51","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib52","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1038\/sj.onc.1207097","article-title":"Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells","volume":"22","author":"Burger","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.02.043_bib53","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.2235846100","article-title":"A\u00a0small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors","volume":"100","author":"Rubin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.02.043_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(03)00824-X","article-title":"T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer","volume":"550","author":"Tamamura","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2018.02.043_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2004.05.155","article-title":"A\u00a0single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma","volume":"320","author":"Takenaga","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.02.043_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/1535-7163.29.3.1","article-title":"CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer","volume":"3","author":"Mori","year":"2004","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.02.043_bib57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood-2004-03-0799","article-title":"Chemokine receptor expression in EBV-associated lymphoproliferation in hu\/SCID mice: implications for CXCL12\/CXCR4 axis in lymphoma generation","volume":"105","author":"Piovan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib58","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-04-1687","article-title":"Elevated serum levels of stromal-derived factor-1 alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients","volume":"65","author":"Zannettino","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib59","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib60","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/sj.leu.2402998","article-title":"Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in\u00a0vitro","volume":"17","author":"Juarez","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2018.02.043_bib61","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib62","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib63","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.165.11.6590","article-title":"Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4(+) T cell accumulation in rheumatoid arthritis synovium","volume":"165","author":"Nanki","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib64","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3727\/096368916X693563","article-title":"A\u00a0novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain","volume":"26","author":"Wu","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ejmech.2018.02.043_bib65","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12975-017-0538-2","article-title":"Stroke induces mesenchymal stem cell migration to infarcted brain areas via CXCR4 and C-Met signaling","volume":"8","author":"Bang","year":"2017","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib66","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1021\/jm501769r","article-title":"Stem cell mobilizers targeting chemokine receptor CXCR4: renoprotective application in acute kidney injury","volume":"58","author":"Wu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib67","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1039\/c2cs35085h","article-title":"Imaging agents for the chemokine receptor 4 (CXCR4)","volume":"41","author":"Kuil","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2018.02.043_bib68","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","article-title":"CXCR4 ligands: the next big hit?","volume":"58","author":"Walenkamp","year":"2017","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7150\/thno\/v01p0251","article-title":"PET imaging of CXCR4 using copper-64 labeled peptide antagonist","volume":"1","author":"Jacobson","year":"2011","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2018.02.043_bib70","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/RLU.0000000000001092","article-title":"Molecular imaging of chemokine receptor CXCR4 in non-small cell lung cancer using 68Ga-pentixafor PET\/CT: comparison with 18F-FDG","volume":"41","author":"Derlin","year":"2016","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.intimp.2014.05.034","article-title":"Key mediators in the immunopathogenesis of allergic asthma","volume":"23","author":"Hall","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2018.02.043_bib72","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.165.1.499","article-title":"Critical involvement of the chemotactic axis CXCR4\/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease","volume":"165","author":"Gonzalo","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib73","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62562-X","article-title":"AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity","volume":"160","author":"Lukacs","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib74","first-page":"1","article-title":"Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing","volume":"2","author":"Tamamura","year":"2008","journal-title":"Perspect. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib75","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2174\/138955709791012265","article-title":"Targeting CXCR4 in HIV cell-entry inhibition","volume":"9","author":"Steen","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib76","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01727-08","article-title":"The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100","volume":"53","author":"Murakami","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.02.043_bib77","article-title":"Role of CXCR4 in HIV infection and its potential as a therapeutic target (vol 5, pg 1025, 2010)","volume":"5","author":"Murakami","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib78","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2174\/092986707781696618","article-title":"Small molecule CXCR4 chemokine candidates receptor antagonists: developing drug candidates","volume":"14","author":"Khan","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1349-7006.2007.00712.x","article-title":"Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer","volume":"99","author":"Akashi","year":"2008","journal-title":"Canc. Sci."},{"key":"10.1016\/j.ejmech.2018.02.043_bib80","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1541-7786.MCR-09-0463","article-title":"Microenvironmental regulation of chemokine (C-X-C- motif) receptor 4 in ovarian carcinoma","volume":"8","author":"Barbolina","year":"2010","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib81","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1158\/0008-5472.CAN-10-2591","article-title":"CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche","volume":"70","author":"Kim","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib82","doi-asserted-by":"crossref","first-page":"R1208","DOI":"10.1186\/ar1806","article-title":"Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis","volume":"7","author":"De Klerck","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2018.02.043_bib83","first-page":"20","article-title":"SDF-1alpha and CXCR4 as therapeutic targets in cardiovascular disease","volume":"2","author":"Wen","year":"2012","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.ejmech.2018.02.043_bib84","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cardiores.2006.05.002","article-title":"Importance of recruitment of bone marrow-derived CXCR4(+) cells in post-infarct cardiac repair mediated by G-GSF","volume":"71","author":"Misao","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib85","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3858\/emm.2010.42.6.048","article-title":"Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis","volume":"42","author":"Song","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib86","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14728220903196761","article-title":"Targeting the CXCR4\/CXCL12 axis in systemic lupus erythematosus","volume":"13","author":"Chong","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2018.02.043_bib87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/thno.5376","article-title":"Small molecule inhibitors of CXCR4","volume":"3","author":"Debnath","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2018.02.043_bib88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/092986711794480159","article-title":"The CXCL12\/CXCR4 Axis as a therapeutic target in cancer and HIV-1 infection","volume":"18","author":"Patrussi","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib89","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bcp.2008.12.014","article-title":"The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil)","volume":"77","author":"De Clercq","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cytogfr.2005.05.009","article-title":"HIV chemokine receptor inhibitors as novel anti-HIV drugs","volume":"16","author":"Princen","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejmech.2018.02.043_bib91","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0198-072","article-title":"AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor","volume":"4","author":"Donzella","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib92","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bcp.2006.05.010","article-title":"Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4","volume":"72","author":"Fricker","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib93","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.186.8.1383","article-title":"Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4","volume":"186","author":"Schols","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib94","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0026-895X(24)26490-7","article-title":"Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists","volume":"57","author":"De Clercq","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib95","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.qai.0000137371.80695.ef","article-title":"Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection","volume":"37","author":"Hendrix","year":"2004","journal-title":"Jaids-J Acq Imm Def"},{"key":"10.1016\/j.ejmech.2018.02.043_bib96","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.02.043_bib97","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2018.02.043_bib98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1537-2995.2005.04222.x","article-title":"Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist","volume":"45","author":"Liles","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.ejmech.2018.02.043_bib99","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood-2005-02-0468","article-title":"The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone","volume":"106","author":"Flomenberg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1358\/dot.2009.45.7.1395292","article-title":"Plerixafor hydrochloride: a novel agent for the mobilization of peripheral blood stem cells","volume":"45","author":"Cashen","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.ejmech.2018.02.043_bib101","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib102","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-200969030-00007","article-title":"Plerixafor in patients with non-hodgkin's lymphoma or multiple myeloma","volume":"69","author":"Wagstaff","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2018.02.043_bib103","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1200\/JCO.2004.07.131","article-title":"Rapid mobilization of CD34+cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma","volume":"22","author":"Devine","year":"2004","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib104","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1074\/jbc.M309546200","article-title":"Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor - transfer of binding site to the CXCR3 receptor","volume":"279","author":"Rosenkilde","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib105","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1074\/jbc.M010429200","article-title":"Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor","volume":"276","author":"Gerlach","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib106","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1021\/ja0260723","article-title":"Structure and dynamics of metallomacrocycles: recognition of zinc xylyl-bicyclam by an HIV coreceptor","volume":"124","author":"Liang","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.02.043_bib107","doi-asserted-by":"crossref","DOI":"10.1021\/ja807921k","article-title":"Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultrarigid metal complexes","volume":"131","author":"Khan","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.02.043_bib108","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cmdc.201000548","article-title":"Azamacrocyclic metal complexes as CXCR4 antagonists","volume":"6","author":"Tanaka","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.02.043_bib109","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/jm901530b","article-title":"Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of t-cell tropic (X4) HIV-1 replication","volume":"53","author":"Bridger","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/0008-5472.CAN-06-2762","article-title":"Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in\u00a0vivo","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.02.043_bib111","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2005.05.035","article-title":"AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor","volume":"70","author":"Hatse","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib112","series-title":"Chemokine Receptor Binding Heterocyclic Compounds, in","author":"Bridger","year":"2001"},{"key":"10.1016\/j.ejmech.2018.02.043_bib113","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cmdc.201000124","article-title":"Novel monocyclam derivatives as HIV entry inhibitors: design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 Co-receptor","volume":"5","author":"Pettersson","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.02.043_bib114","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/cmdc.200800145","article-title":"Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors","volume":"3","author":"Pettersson","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.02.043_bib115","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/jm070679i","article-title":"Discovery of small molecule CXCR4 antagonists","volume":"50","author":"Zhan","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib116","series-title":"CXCR4 Antagonists for the Treatment of HIV Infection","author":"Shim","year":"2007"},{"key":"10.1016\/j.ejmech.2018.02.043_bib117","series-title":"Preparation of Diazine and Triazine Compounds as Chemokine CXCR4 Receptor Antagonists for the Treatment of Medical Disorders","author":"Liotta","year":"2008"},{"key":"10.1016\/j.ejmech.2018.02.043_bib118","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1021\/jm100786g","article-title":"Dipyrimidine amines: a novel class of chemokine receptor. Type 4 antagonists with high specificity","volume":"53","author":"Zhu","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib119","article-title":"Development of a unique small molecule modulator of CXCR4","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.02.043_bib120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2016.04.040","article-title":"Symmetrical bis-tertiary amines as novel CXCR4 inhibitors","volume":"118","author":"Bai","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib121","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1016\/j.bmc.2016.08.018","article-title":"Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors","volume":"24","author":"Gaines","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib122","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2016.11.026","article-title":"Development of CXCR4 modulators by virtual HTS of a novel amidesulfamide compound library","volume":"126","author":"Bai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib123","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1021\/jm300862u","article-title":"Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells","volume":"55","author":"Ros-Blanco","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib124","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1021\/jm100073m","article-title":"Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of t-tropic (X4) HIV-1 replication","volume":"53","author":"Skerlj","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1021\/op8000993","article-title":"AMD070, a CXCR4 chemokine receptor antagonist: practical large-scale laboratory synthesis","volume":"12","author":"Crawford","year":"2008","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2018.02.043_bib126","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/j.bmcl.2009.07.037","article-title":"Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1","volume":"19","author":"Gudmundsson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib127","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1016\/j.bmcl.2009.09.056","article-title":"Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1","volume":"19","author":"Gudmundsson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib128","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.bmcl.2010.02.030","article-title":"Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1","volume":"20","author":"Catalano","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib129","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.bmcl.2010.02.053","article-title":"Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents","volume":"20","author":"Miller","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib130","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.bmcl.2010.03.118","article-title":"Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity","volume":"20","author":"Miller","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bmcl.2010.11.023","article-title":"Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication","volume":"21","author":"Skerlj","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib132","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bmcl.2011.01.021","article-title":"Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication","volume":"21","author":"Skerlj","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib133","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1021\/jm801065q","article-title":"Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in\u00a0vitro and in\u00a0vivo","volume":"51","author":"Thoma","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib134","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/AAC.01293-09","article-title":"Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist","volume":"54","author":"Jenkinson","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.02.043_bib135","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/ml400183q","article-title":"Discovery of tetrahydroisoquinoline-based CXCR4 antagonists","volume":"4","author":"Truax","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.02.043_bib136","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1016\/j.bmcl.2015.04.036","article-title":"Discovery of novel N-aryl piperazine CXCR4 antagonists","volume":"25","author":"Zhao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib137","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0630420100","article-title":"A\u00a0duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity","volume":"100","author":"Ichiyama","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.02.043_bib138","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1021\/acs.jmedchem.5b00987","article-title":"Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636)","volume":"58","author":"Zachariassen","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib139","series-title":"Novel Nitrogenous Compound and Use Thereof","author":"Toru Yamazaki","year":"2004"},{"key":"10.1016\/j.ejmech.2018.02.043_bib140","series-title":"Amine Compounds and Use Thereof","author":"Toru Yamazaki","year":"2007"},{"key":"10.1016\/j.ejmech.2018.02.043_bib141","series-title":"Basic Amine Compound and Use Thereof","author":"Saitou","year":"2006"},{"key":"10.1016\/j.ejmech.2018.02.043_bib142","series-title":"Amine Compounds and Use Thereof","author":"Toru Yamazaki","year":"2009"},{"key":"10.1016\/j.ejmech.2018.02.043_bib143","series-title":"Preparation of Basic Group-containing Heterocyclic Compounds as CXCR4 Antagonists","author":"Kokubo","year":"2006"},{"key":"10.1016\/j.ejmech.2018.02.043_bib144","series-title":"Preparation of Heterocyclic Compounds Containing Basic Group as CXCR4 Antagonists","author":"Kokubo","year":"2007"},{"key":"10.1016\/j.ejmech.2018.02.043_bib145","series-title":"Substituted Benzodiazepines as Inhibitors of the Chemokine Receptor CXCR4 and Use in the Inhibition of HIV Infectivity","author":"Marshall","year":"2005"},{"key":"10.1016\/j.ejmech.2018.02.043_bib146","series-title":"Preparation of Nitrogen-containing Heterocyclic Compounds as CXCR4 Regulators","author":"Habashita","year":"2004"},{"key":"10.1016\/j.ejmech.2018.02.043_bib147","series-title":"Preparation of Aminopyrimidines as Chemokine CXCR4 Receptor Ligands","author":"Yen","year":"2006"},{"key":"10.1016\/j.ejmech.2018.02.043_bib148","series-title":"Heterocyclic Compounds as Chemokine Receptor Inhibitors and Their Preparation and Use in the Treatment CXCR4-mediated Disease","author":"Yen","year":"2009"},{"key":"10.1016\/j.ejmech.2018.02.043_bib149","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3727\/096368914X681739","article-title":"CXCR4 antagonist TG-0054 mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction","volume":"24","author":"Hsu","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ejmech.2018.02.043_bib150","series-title":"Preparation of (Heterocyclic) Aromatic Polyamines for Treatment of Retinopathy and for Repairing Tissue Damage","author":"Yen","year":"2008"},{"key":"10.1016\/j.ejmech.2018.02.043_bib151","series-title":"Polyamine Compounds and Their Preparation and Use in the Treatment of Retinopathy and Repairing Tissue Damage","author":"Yen","year":"2008"},{"key":"10.1016\/j.ejmech.2018.02.043_bib152","series-title":"Preparation of Benzimidazole Polyamine Compounds","author":"Wu","year":"2006"},{"key":"10.1016\/j.ejmech.2018.02.043_bib153","series-title":"Compositions Comprising CXCR4 Inhibitors for Treating Ophthalmic Diseases","author":"Sullivan","year":"2006"},{"key":"10.1016\/j.ejmech.2018.02.043_bib154","series-title":"Preparation of Indoles, Indazoles, Benzimidazoles and Their Analogs as Chemokine Receptor CXCR4 and CCR7 Inhibitors","author":"Thomas","year":"2007"},{"key":"10.1016\/j.ejmech.2018.02.043_bib155","series-title":"Preparation of Benzyltetrahydronaphthyridinylethylurea Derivatives and Analogs for Use as HIV Blockers","author":"Shipps","year":"2010"},{"key":"10.1016\/j.ejmech.2018.02.043_bib156","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1021\/ja025761b","article-title":"First artificial receptors and chemosensors toward phosphorylated peptide in aqueous solution","volume":"124","author":"Ojida","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.02.043_bib157","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/jm060025u","article-title":"Identification of a new class of low molecular weight antagonists against the chemokine receptor CXCR4 having the dipicolylamine-zinc(II) complex structure","volume":"49","author":"Tamamura","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib158","series-title":"Novel CXCR4 Antagonist and Use Thereof","author":"Fujii","year":"2007"},{"key":"10.1016\/j.ejmech.2018.02.043_bib159","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cmdc.201200390","article-title":"Low-molecular-weight CXCR4 ligands with variable spacers","volume":"8","author":"Narumi","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.02.043_bib160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cmdc.201100525","article-title":"Discovery of novel stem cell mobilizers that target the CXCR4 receptor","volume":"7","author":"Wu","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.02.043_bib161","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1021\/jm501772w","article-title":"Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors","volume":"58","author":"Wu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib162","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/AAC.00709-10","article-title":"Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4","volume":"55","author":"Wilkinson","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.02.043_bib163","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.bmcl.2013.01.107","article-title":"Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection","volume":"23","author":"Wilkinson","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.02.043_bib164","doi-asserted-by":"crossref","first-page":"12996","DOI":"10.1128\/JVI.78.23.12996-13006.2004","article-title":"Inhibition of human immunodeficiency virus replication by a dual CCR5\/CXCR4 antagonist","volume":"78","author":"Princen","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.02.043_bib165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/acsmedchemlett.5b00036","article-title":"Pyrazolo-piperidines exhibit dual inhibition of CCR5\/CXCR4 HIV entry and reverse transcriptase","volume":"6","author":"Cox","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.02.043_bib166","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.02.043_bib167","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","article-title":"The chemokine SDF-1 alpha triggers CXCR4 receptor dimerization and activates the JAK\/STAT pathway","volume":"13","author":"Vila-Coro","year":"1999","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2018.02.043_bib168","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1074\/jbc.M210140200","article-title":"Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor","volume":"278","author":"Babcock","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib169","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1074\/jbc.M411151200","article-title":"Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers","volume":"280","author":"Percherancier","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.043_bib170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2018.02.043_bib171","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1349-7006.2008.00997.x","article-title":"Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis","volume":"100","author":"Hamatake","year":"2009","journal-title":"Canc. Sci."},{"key":"10.1016\/j.ejmech.2018.02.043_bib172","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/1535-7163.MCT-05-0261","article-title":"Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions","volume":"5","author":"Wang","year":"2006","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.02.043_bib173","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-2478(01)00228-0","article-title":"Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1 alpha: implications for development of selective CXCR4 antagonists","volume":"78","author":"Gupta","year":"2001","journal-title":"Immunol. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:08:25Z","timestamp":1751407705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418301739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":173,"alternative-id":["S0223523418301739"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.043","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}